Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration

被引:11
|
作者
Palis, Heather [1 ,2 ]
Gan, Wenqi [1 ,3 ]
Xavier, Chloe [1 ]
Desai, Roshni [1 ]
Scow, Marnie [1 ,4 ]
Sedgemore, Kali-Olt [1 ,5 ]
Greiner, Leigh [6 ]
Nicholls, Tonia [2 ,7 ]
Slaunwhite, Amanda [1 ,4 ]
机构
[1] BC Ctr Dis Control, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada
[3] Univ Connecticut, Dept Publ Hlth Sci, Sch Med, Farmington, CT USA
[4] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[5] Coalit Peers Dismantling Drug War, Vancouver, BC, Canada
[6] BC Correct, Victoria, BC, Canada
[7] BC Mental Hlth & Subst Use Serv, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
DEFICIT HYPERACTIVITY DISORDER; DRUG OVERDOSE; DOUBLE-BLIND; COCAINE-USE; METHYLPHENIDATE; METAANALYSIS; RELEASE;
D O I
10.1001/jamanetworkopen.2022.43653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Studies have suggested a rise in opioid- and stimulant-involved overdoses in recent years in North America. This risk may be acute for individuals who have had contact with the criminal justice system, who are particularly vulnerable to overdose risk. OBJECTIVE To examine the association of opioid and/or stimulant use disorder diagnoses with overdose (fatal and nonfatal) among people with histories of incarceration. DESIGN, SETTING, AND PARTICIPANTS In this cohort study, population-based health and corrections data were retrieved from the British Columbia Provincial Overdose Cohort, which contains a 20% random sample of residents of British Columbia. The analysis included all people in the 20% random sample who had a history of incarceration between January 1, 2010, and December 31, 2014. Outcomes were derived from 5-years of follow-up data (January 1, 2015, to December 31, 2019). Statistical analysis took place from January 2022 to June 2022. EXPOSURES Substance use disorder diagnosis type (ie, opioid use disorder, stimulant use disorder, both, or neither), sociodemographic, health, and incarceration characteristics. MAIN OUTCOMES AND MEASURES Hazard ratios (HRs) are reported from an Andersen-Gill model for recurrent nonfatal overdose events and from a Fine and Gray competing risk model for fatal overdose events. RESULTS The study identified 6816 people (5980 male [87.7%]; 2820 aged <30 years [41.4%)) with histories of incarceration. Of these, 293 (4.3%) had opioid use disorder only, 395 (6.8%) had stimulant use disorder only, and 281 (4.1%) had both diagnoses. During follow-up, 1655 people experienced 4026 overdoses including 3781(93.9%) nonfatal overdoses, and 245 (6.1%) fatal overdoses. In adjusted analyses, the hazard of both fatal (HR, 2.39; 95% CI, 1.48-3.86) and nonfatal (HR, 2.45; 95% CI, 1.94-3.11) overdose was highest in the group with both opioid and stimulant use disorder diagnoses. CONCLUSIONS AND RELEVANCE This cohort study of people with a history of incarceration found an elevated hazard of fatal and nonfatal overdose among people with both opioid and stimulant use disorder diagnoses. This study suggests an urgent need to address the service needs of individuals who have had contact with the criminal justice system and who co-use opioids and stimulants.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder
    Dahlman, Disa
    Ohlsson, Henrik
    Edwards, Alexis C.
    Sundquist, Jan
    Hakansson, Anders
    Sundquist, Kristina
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2021, 16 (01)
  • [2] Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder
    Disa Dahlman
    Henrik Ohlsson
    Alexis C. Edwards
    Jan Sundquist
    Anders Håkansson
    Kristina Sundquist
    Substance Abuse Treatment, Prevention, and Policy, 16
  • [3] Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
    Larochelle, Marc R.
    Bernson, Dana
    Land, Thomas
    Stopka, Thomas J.
    Wang, Na
    Xuan, Ziming
    Bagley, Sarah M.
    Liebschutz, Jane M.
    Walley, Alexander Y.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (03) : 137 - +
  • [4] Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Mortality
    Brennan, Lawrence V.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (06) : 430 - 430
  • [5] Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities
    Korthuis, P. Todd
    Cook, Ryan R.
    Foot, Canyon A.
    Leichtling, Gillian
    Tsui, Judith, I
    Stopka, Thomas J.
    Leahy, Judith
    Jenkins, Wiley D.
    Baker, Robin
    Chan, Brian
    Crane, Heidi M.
    Cooper, Hannah L.
    Feinberg, Judith
    Zule, William A.
    Go, Vivian F.
    Estadt, Angela T.
    Nance, Robin M.
    Smith, Gordon S.
    Westergaard, Ryan P.
    Van Ham, Brent
    Brown, Randall
    Young, April M.
    JAMA NETWORK OPEN, 2022, 5 (08) : e2226544
  • [6] Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose
    Jones, Christopher M.
    Shoff, Carla
    Blanco, Carlos
    Losby, Jan L.
    Ling, Shari M.
    Compton, Wilson M.
    JAMA INTERNAL MEDICINE, 2024, 184 (08) : 954 - 962
  • [7] Prevalence of Opioid Use Disorder and Opioid Overdose Rates Among People With Mental Illness
    Chen, Qingxian
    Gopaldas, Manesh
    Castillo, Felipe
    Leckman-Westin, Emily
    Nunes, Edward V.
    Levin, Frances R.
    Finnerty, Molly T.
    PSYCHIATRIC SERVICES, 2024, 75 (10) : 953 - 960
  • [8] Categorization of Opioid Use Among Pregnant People and Association With Overdose or Death
    Camden, Andi
    To, Teresa
    Ray, Joel G.
    Gomes, Tara
    Bai, Li
    Guttmann, Astrid
    JAMA NETWORK OPEN, 2022, 5 (05) : E2214688
  • [9] Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US
    Jarlenski, Marian
    Chen, Qingwen
    Gao, Alice
    Rothenberger, Scott D.
    Krans, Elizabeth E.
    JAMA NETWORK OPEN, 2022, 5 (04) : E227964
  • [10] MORTALITY AFTER NONFATAL OPIOID OVERDOSE: MEDICATIONS FOR OPIOID USE DISORDER ARE ASSOCIATED WITH LOWER RISK
    Larochelle, Marc
    Bernson, Dana
    Land, Thomas
    Stopka, Thomas
    Walley, Alexander Y.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S250 - S250